Rabies Vaccine Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast 2030
The global rabies vaccines market was
estimated to be worth USD 1.1 billion, and over the course of the projection
period, a CAGR of 5.1% is anticipated. The market for rabies vaccines is
expanding dramatically due to the rising incidence of rabies. Individuals who
receive three shots are less likely to contract rabies. A statistic states that
over 59,000 people worldwide pass away from rabies each year.
Africa and the Asia-Pacific region account for the majority
of rabies cases. Most people affected by the disease are under 15 years old, and
the bulk of cases are located in rural areas. The disease's lack of awareness
is fueling the market's expansion. The market is growing because more
individuals are becoming aware of the need to diagnosis bacterial and viral
diseases early on.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/rabies-vaccine-market
Impact of Covid-19
Covid-19's severe lockdown circumstances, social distance,
and interruption of the supply chain severely hurt the demand for rabies
vaccines. When the pandemic first started, the CID-19 pandemic was the main
concern for the public. However, when things started to stabilize, the market
for rabies vaccines saw a notable increase once more as a result of an increase
in rabies cases. A fatal viral illness that infects mammals, including humans,
is rabies. The virus is spread by the afflicted animal's saliva.
Growth Drivers
The global rise in dog bite incidences is the primary
driver of this market's expansion. The global public's growing knowledge of
viral diseases is fueling the market's expansion. An further factor
contributing to this market's growth is the rise in government initiatives. One
barrier, though, is that people in rural areas are not aware of rabies.
The industry is expanding as a result of the growing number
of pets. The market for rabies vaccines is
expanding due to technological developments in vaccine manufacturing. The
industry is expanding significantly due to government initiatives and efforts
to restrict the spread of rabies. The demand for vaccinations is being driven by
the expansion of immunization programs in developing nations across the globe.
The market is expanding as people become more inclined to
keep dogs at home. The government's efforts to eradicate rabies, growing public
concern over animal health, and developments in vaccination technology are all
major factors propelling the market's expansion.
Segmentation
Vaccine Type
· Animal
Vaccine
· Human
Vaccine
Administration
· Oral
· Intramuscular
· Intradermal
Distribution Channel
· Hospital
· Pharmacies
· Retail
Pharmacies
· Online
Pharmacies
Regional Outlook
· Asia
Pacific
· North
America
· Europe
· Latin
America
· Middle
East and Africa
Key Players
· Sanofi
Pasteur
· GlaxoSmithKline
Plc
· Pfizer
Inc
· Merck
and Co.
· Boehringer
Ingelheim
· Zoetis
Inc
· Elanco
· HDCV
· Emovax
· Rabies
Vaccine Human Diploid Cell Culture
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/rabies-vaccine-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment